Healthcare - Biotechnology - NASDAQ - US
$ 0.416
4.16 %
$ 26.8 M
Market Cap
-0.69
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
522.33%
EBIT
Estimate
30.81%
Net Income
Estimate
--36.12%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
GlycoMimetics, Inc.
GLYC has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart GLYC
EBIT FORECAST
EBIT Forecast Chart GLYC
NET INCOME FORECAST
Net Income Chart GLYC